发明名称 | TCR/MHCII-collagen interaction inhibitors useful for treatment of rheumatoid arthritis | ||
摘要 | The T cells specific to human collagen type II, one of the possible autoantigens, have a crucial role in the development of rheumatoid arthritis in the context of HLA-DR4. The protein-protein interactions between the T cell receptor (TCR) and the type II collagen linked to the allele MHC of class II HLA-DR4 may thus represent the target for the development of new drugs against rheumatoid arthritis. Using computational virtual screening techniques, families of pharmacologically active molecules have been identified that interfere with the TCR/collagen ll-MHCII interaction. The compounds identified here open up new possibilities in the treatment of rheumatoid arthritis. | ||
申请公布号 | US9630954(B2) | 申请公布日期 | 2017.04.25 |
申请号 | US201314389759 | 申请日期 | 2013.04.02 |
申请人 | Consiglio Nazionale delle Ricerche;Università Cattolica del Sacro Cuore | 发明人 | De Rosa Maria Cristina;Ria Francesco;Giardina Bruno;Ferraccioli Gianfranco;Pirolli Davide;Nicolo′ Chiara |
分类号 | C07D207/08;C07D401/04;A61K31/4025;A61K31/4439;C07D407/12;A61K31/343;A61K31/40;A61K31/403;C07D409/12;C07D207/06;C07D209/86;C07D209/88;C07D307/91;C07C251/86;A61K31/165;A61K31/381 | 主分类号 | C07D207/08 |
代理机构 | Nixon & Vanderhye PC | 代理人 | Nixon & Vanderhye PC |
主权项 | 1. A method for treating rheumatoid arthritis, comprising administering an inhibitor of interaction between T cells and a complex of MHC-II and human collagen type II or an antigenic fragment thereof to a patient who is HLA-DR4 positive, HLA-DR7 positive, or both HLA-DR4 positive and HLA-DR7 positive; wherein said inhibitor is a compound of formula (I): wherein R is selected from the group consisting of hydrogen, a methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl, phenylethyl group, and substituted o-chloro, o-bromo or o-iodo forms thereof; R1 is selected from the group consisting of: phenyl, 2′-pyridyl, 3′-pyridyl, 4′-pyridyl, o-iodophenyl, m-iodophenyl, p-iodophenyl, o-chlorophenyl, m-chlorophenyl, and p-chlorophenyl; and is in the form of a diastereoisomeric mixture, racemic mixture, isolated enantiomer, or salts thereof. | ||
地址 | Rome IT |